Related Experiment Video
Updated: Mar 5, 2026
09:06
Efficient and Site-specific Antibody Labeling by Strain-promoted Azide-alkyne Cycloaddition
Published on: December 23, 2016
22.5K
Affibody molecules as engineered protein drugs.
Fredrik Y Frejd1,2, Kyu-Tae Kim3
1Affibody AB, Solna, Sweden.
Experimental & Molecular Medicine
|March 25, 2017
Summary
Affibody molecules show promise as diagnostic and therapeutic tools. Early clinical data suggest these engineered protein scaffolds are safe and effective in humans for complex diseases.
Area of Science:
- Biotechnology
- Molecular Engineering
- Medical Diagnostics and Therapeutics
Background:
- Affibody molecules are engineered protein scaffolds used for molecular recognition.
- They offer advantages in size and ease of engineering compared to traditional antibodies.
- Preclinical studies have explored their diagnostic and therapeutic potential.
Purpose of the Study:
- To review the current state of Affibody molecule applications in diagnostics and therapeutics.
- To highlight emerging clinical evidence for their efficacy and safety in humans.
- To discuss their utility in developing advanced therapeutic constructs like AffiMabs.
Main Methods:
- Review of preclinical studies on Affibody molecules.
- Analysis of early-stage clinical trial data.
- Examination of Affibody molecule engineering for multispecific constructs.
Main Results:
- Accumulating clinical evidence supports the efficacy and safety of Affibody molecules in humans.
- Affibody molecules are suitable for molecular recognition in diagnostic and therapeutic contexts.
- Engineered Affibody molecules, such as AffiMabs, can potentiate antibodies for complex diseases.
Conclusions:
- Affibody molecules represent a promising class of alternative scaffolds for medical applications.
- Their small size and engineerability facilitate the development of innovative diagnostic and therapeutic strategies.
- Affibody molecules are advancing towards clinical translation for various diseases.
Related Concept Videos
01:28Drug Products: Biologics, Biosimilars and Interchangeables
319
Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...
319
01:27Transducer Mechanism: Enzyme-Linked Receptors
4.6K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
4.6K
01:20Factors Affecting Protein-Drug Binding: Protein-Related Factors
627
Drug binding to proteins is a key aspect of pharmacokinetics and can influence a drug's distribution, absorption, and elimination in the body. Several factors, including the drug's physiochemical properties, protein concentration, disease states, and the number of binding sites on the protein, influence this process.
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be...
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be...
627
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
64
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
64
01:24Principles of Drug Action
9.2K
Drugs are chemical substances that modify biological responses by interacting with macromolecular targets such as receptors, ion channels, transporters, and enzymes. Pharmacodynamics describes the course of action of drugs leading to the physiological effect at a specific site in the body.
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
9.2K
01:18Factors Affecting Protein-Drug Binding: Drug-Related Factors
559
Drug binding to proteins is a complex phenomenon influenced by various drug-related factors, each playing a significant role in the interaction between drugs and proteins within the body.
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In...
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In...
559